ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,954.50
1.59%
Dow Jones
43,840.91
1.39%
US Dollar vs MXN
20.55
0.02%
Brent Oil
73.045
0.00%
Bitcoin
85,260.05
-0.90%
Pepperstone
Advertisement
Registration Strip Icon for monitor Monitoree múltiples cotizaciones en tiempo real de los principales intercambios, como la Bolsa de Valores de Londres, NASDAQ, NYSE, AMEX, Bovespa y más.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ

  6. Cartesian Therapeutics Inc (RNAC) Cotización

Cartesian Therapeutics Inc

Cartesian Therapeutics Inc (RNAC)

NASDAQ
18.84
0.83
(4.61%)
Cerrado 02 Marzo 3:00PM
Delayed by 15 minutes
18.97
0.13
(0.69%)
Fuera de horario: 6:59PM
Delayed by 15 minutes

Discusiones en tiempo real e ideas comerciales: opere con confianza con nuestra poderosa plataforma.

Premium

Estadísticas y detalles clave

Último Precio
18.84
Postura de Compra
16.01
Postura de Venta
22.00
Volume Operado de la Acción
49,660
17.76 Rango del Día 18.97
11.665 Rango de 52 semanas 41.87
Capitalización de Mercado [m]
478.817M
Precio Anterior
18.01
Precio de Apertura
17.76
Hora
7
@
18.84
Última hora de negociación
Volumen financiero
US$ 920,492
Precio Promedio Ponderado
18.5359
Volumen promedio (3 m)
100,588
Acciones en circulación
25,414,898
Rendimiento del Dividendo
-
Ratio Precio/Utilidad
-2.19
Beneficio por acción (BPA)
-8.64
turnover
26M
Beneficio neto
-219.71M

Acerca de Cartesian Therapeutics Inc

Cartesian Therapeutics, Inc. is a clinical-stage company. The Company is engaged in developing messenger ribonucleic acids (mRNA) cell therapies for the treatment of autoimmune diseases. It is leveraging its proprietary technology and manufacturing platform, RNA Armory, to develop mRNA cell therapie... Cartesian Therapeutics, Inc. is a clinical-stage company. The Company is engaged in developing messenger ribonucleic acids (mRNA) cell therapies for the treatment of autoimmune diseases. It is leveraging its proprietary technology and manufacturing platform, RNA Armory, to develop mRNA cell therapies for autoimmune diseases. Its lead asset e, Descartes-08, is an autologous mRNA chimeric antigen receptor T-cell therapy (CAR-T) directed against the B cell maturation antigen (BCMA), that the Company is developing for the treatment of autoimmune diseases. Descartes-08 is in Phase II clinical development. Descartes-15 is a next-generation, autologous anti-BCMA mRNA CAR-T. Using its proprietary technology and manufacturing platform, it designed Descartes-15 to be more resistant than Descartes-08 to recycling of the CAR upon multiple antigen exposures. It is developing Descartes-33 to deliver a combination of therapeutic proteins that target key drivers in the pathogenesis of autoimmunity. Mostrar más

Sector
Pharmaceutical Preparations
Industria
Pharmaceutical Preparations
Sitio web
www.selectabio.com
Sede
Wilmington, Delaware, USA
Fundado
-
Cartesian Therapeutics Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker RNAC. The last closing price for Cartesian Therapeutics was US$18.01. Over the last year, Cartesian Therapeutics shares have traded in a share price range of US$ 11.665 to US$ 41.87.

Cartesian Therapeutics currently has 25,414,898 shares in issue. The market capitalisation of Cartesian Therapeutics is US$457.72 million. Cartesian Therapeutics has a price to earnings ratio (PE ratio) of -2.19.

RNAC Últimas noticias

Más noticias

Form 8-K - Current report
Edgar (US Regulatory)
27 Enero 2025
RNAC (4.61%)

Form EFFECT - Notice of Effectiveness
Edgar (US Regulatory)
13 Enero 2025
RNAC (4.61%)

Form EFFECT - Notice of Effectiveness
Edgar (US Regulatory)
13 Enero 2025
RNAC (4.61%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
13 Enero 2025
RNAC (4.61%)

Form POS AM - Post-Effective amendments for registration statement
Edgar (US Regulatory)
10 Enero 2025
RNAC (4.61%)

Form POS AM - Post-Effective amendments for registration statement
Edgar (US Regulatory)
10 Enero 2025
RNAC (4.61%)
Período †Variación(Ptos)Variación %AperturaPrecio MáximoPrecio MínimoAvg. Vol. diarioPrecio Promedio Ponderado
1-1.14-5.7057057057119.9819.9817.78974818.75984572CS
4-0.74-3.7793667007219.582017.696230219.03031215CS
12-4.29-18.547341115423.1326.516.410058819.16565612CS
264.7333.522324592514.1126.512.7710404119.15800511CS
52-2.76-12.777777777821.641.8711.66519154419.03478908CS
156-5.355-22.132672039724.19542.611.66533509722.54923443CS
260-5.355-22.132672039724.19542.611.66533509722.54923443CS

RNAC - Preguntas Frecuentes

¿Cuál es el precio actual de las acciones de Cartesian Therapeutics?
El precio actual de las acciones de Cartesian Therapeutics es US$ 18.84
¿Cuántas acciones de Cartesian Therapeutics están en circulación?
Cartesian Therapeutics tiene 25,414,898 acciones en circulación
¿Cuál es la capitalización de mercado de Cartesian Therapeutics?
La capitalización de mercado de Cartesian Therapeutics es USD 457.72M
¿Cuál es el rango de negociación de 1 año para el precio de las acciones de Cartesian Therapeutics?
Cartesian Therapeutics ha negociado en un rango de US$ 11.665 a US$ 41.87 durante el último año
¿Cuál es el ratio PE (precio/beneficio) de Cartesian Therapeutics?
El ratio precio/beneficio de Cartesian Therapeutics es -2.19
¿Cuál es el ratio de efectivo a ventas de Cartesian Therapeutics?
El ratio de efectivo a ventas de Cartesian Therapeutics es 18.54
¿Cuál es la moneda de reporte de Cartesian Therapeutics?
Cartesian Therapeutics presenta sus resultados financieros en USD
¿Cuál es el último ingresos anual de Cartesian Therapeutics?
El último ingresos anual de Cartesian Therapeutics es USD 26M
¿Cuál es el último beneficio anual de Cartesian Therapeutics?
El último beneficio anual de Cartesian Therapeutics es USD -219.71M
¿Cuál es la dirección registrada de Cartesian Therapeutics?
La dirección registrada de Cartesian Therapeutics es CORPORATION TRUST CENTER, 1209 ORANGE STREET, WILMINGTON, DELAWARE, 19801
¿Cuál es la dirección del sitio web de Cartesian Therapeutics?
La dirección del sitio web de Cartesian Therapeutics es www.selectabio.com
¿En qué sector industrial opera Cartesian Therapeutics?
Cartesian Therapeutics opera en el sector PHARMACEUTICAL PREPARATIONS

Movimientos

Ver todo
  • Volumen
  • % Mayores Alzas
  • % Mayores Bajas
SímboloPrecioVol.
STAKSTAK Inc
US$ 3.97
(156.13%)
173.35k
ORGOOrganogenesis Holdings Inc
US$ 6.21
(102.28%)
58.69M
TRNRInteractive Strength Inc
US$ 2.57
(67.97%)
192.48M
PMAXPowell Max Ltd
US$ 0.511
(43.54%)
136.35M
ARBBARB IOT Group Ltd
US$ 0.6635
(38.23%)
58.86M
NVNINVNI Group Ltd
US$ 0.99
(-50.50%)
72.28M
SPGCSacks Parente Golf Inc
US$ 0.2085
(-48.65%)
57.4M
ADGMAdagio Medical Holdings Inc
US$ 0.8081
(-47.53%)
756.64k
PRAXPraxis Precision Medicines Inc
US$ 38.60
(-40.64%)
3.17M
SAGSAG Holdings Ltd
US$ 1.19
(-38.97%)
788.89k
NVDANVIDIA Corporation
US$ 124.92
(3.97%)
379.97M
TRNRInteractive Strength Inc
US$ 2.57
(67.97%)
192.48M
TSLLDirexion Daily TSLA Bull 2X Trust ETF
US$ 13.44
(7.78%)
153.64M
PMAXPowell Max Ltd
US$ 0.511
(43.54%)
136.35M
LCIDLucid Group Inc
US$ 2.22
(-0.45%)
134.28M

Discusión

Ver feed completo
SHORENUFFSTUFF SHORENUFFSTUFF 5 minutos hace
Father O'Malley answers the phone. 'Hello, is this Father O'Malley?'
'It is!'
'This is the IRS. Can you help us?'
'I can!'
'Do you know a Ted Houlihan?'
'I do!'
'Is he a member of your congregation?'
'He is!'
'Did he donate $10,000 to the churc
pos_stock_hoarder pos_stock_hoarder 6 minutos hace
Too bad that we can't bet on the outcomes. Other than Giuliani winning some years ago after Dumbkins, it's easy pickings betting on a libtard winning.
biowin biowin 7 minutos hace
Some hope for Bioamber's shareholders spoken here
https://youtu.be/mYhtDb0eKvw?si=8i4juCq228A30cRH

Bioamber was funded by sdtc
https://www.newswire.ca/news-releases/bioamber-secures-7-million-grant-from-sdtc-514592191.html
pos_stock_hoarder pos_stock_hoarder 8 minutos hace
Why don't all those protesters grab rifles and ammo and go fight for their own homeland?

Crickets.......
100lbStriper 100lbStriper 9 minutos hace
enjoy life........... Sublime - What I Got........... who says a white boy cant rap lol !!!
https://www.youtube.com/watch?v=jjxXhxcIbG0
ddls ddls 11 minutos hace
How did the much promoted "No-Pain-Act" work out?..😎
BIEL
trader53 trader53 11 minutos hace
DPLS 0.00035 - Point of Maximum Financial Opportunity


https://investorshub.advfn.com/uimage/uploads/2025/3/2/qhbmsDennis_Feb_28_2025_George_will_come_with_me_to_Dubai_in_April_and_in_D.C._early_March.PNG

https://investorshub.advfn.com/uimage/uploads/2025/3/2/yc
DPLS MFI
100lbStriper 100lbStriper 11 minutos hace
sure you can. its something good in a bad world, but it is real............

Sublime - What I Got
https://www.youtube.com/watch?v=jjxXhxcIbG0
NLST
oystersnbeer oystersnbeer 13 minutos hace
Trickle Down Stupidity

There is no bottom to a basket full of Magats.
MasterBlastr MasterBlastr 13 minutos hace
You need to work to lift yourself from stupidity
LandPro LandPro 16 minutos hace
It is never an easy task to move a bloated share structure.
RDAR
x993231 x993231 17 minutos hace
Silicon photonics is maxed out, it had a good run, AI is stressing the entire ecosystem. The demand for this is large enough to justify a consortium type approach.  Wouldn't that be interesting.  The members of the group would pool resources and share ownership, multiple verticals could be addresse
LWLG
quester614 quester614 18 minutos hace
Like you say time will tell. I say time is SHORT for this SCAM and that PROOF will be forthcoming soon. Will the share price TANK when the case is DISMISSED????????🤔
BTW it's XERI that has dragged this SCAM out with lawsuits. Why didn't XERI use Mediation if they had a case over the E
XERI
LandPro LandPro 18 minutos hace
Zero facts this ticker has anything to do with crypto.🤥
BLLB
livefree_ordie livefree_ordie 18 minutos hace
“The closest thing to eternal life on earth is a Government program”. Thank you President Reagan.
Slojab Slojab 19 minutos hace
You've really gone off the deep end, haven't you?
livefree_ordie livefree_ordie 20 minutos hace
Yeas and they are still eating them!!!!
pos_stock_hoarder pos_stock_hoarder 20 minutos hace
He'll win too.

And his first act will be to house criminal illegals with the poor folks in nursing homes!
livefree_ordie livefree_ordie 21 minutos hace
So true totally agree especially you last point this is a forty something fifty something position not 70.
livefree_ordie livefree_ordie 21 minutos hace
So true totally agree especially you last point this is a forty something fifty something position not 70.
TJG TJG 21 minutos hace
Great post OS and if people want the condensed version they need to know this. MTi and OMT are and will continue to be TWO separate companies. They will work together on projects and they will work separately on projects. Their revenue will be added into the parent company, Affluence Corp. 
AFFU
ssc ssc 21 minutos hace
I see. And you just happen to know exactly that peterj was referring to a comic book character instead of a real person; as if your minds were one lol. Asinine, but easy to understand coming from someone who drew a sketch of a head, created a fake Facebook account for it, and swore it was erhe's l
ERHE
Number sleven Number sleven 21 minutos hace
https://clinicaltrials.gov/study/NCT06637657?term=Amarin%20&page=2&rank=12
Sleven,
AMRN

Su Consulta Reciente

NASDAQ
RNAC
Cartesian Therapeutics
BOV
PETR4
PETROBRAS PN
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2025 ADVFN PLC - Todos los derechos reservados

Quitar anuncios

Suscríbete a una experiencia sin publicidad

Sin anuncios

Pruébalo ahora

Mantenga los anuncios